A startup tackling the 'dumb problems' at the intersection of AI and bio, accuracy of AI scribes, and more.

UniQure has submitted its Huntington’s gene therapy to the FDA, investors remain unenthusiastic on Novo Nordisk, and more of ...

The next DSM and the algorithm, an unexpected discovery on alpha-gal syndrome, and more health news from Morning Rounds ...

Analysts say private deals involve drugmakers agreeing to lower prices in Medicaid, where prices are low, in return for no ...

The new DSM, expected in 2030, should address the digital environments of eating disorders patients, experts write.

The whole of my field has been flattened into a single lazy question: Did the health care system fail her?” writes Jennifer ...

This is not a moment our community can afford to spend fighting itself,” writes American Diabetes Association CEO Charles ...

Shihipar directs narrative projects and policy impact initiatives at the People, Place, and Health Collective at the Brown ...

More Trump drug pricing deals, GSK speeds up development of mRNA flu vaccine, and other biotech news ...

The federal spending bill has an important provision for researchers, and Trump announced more MFN deals with pharma firms.

The House voted to pass a stopgap funding bill that, for now, blocks a White House proposal to give political appointees more ...

Here are some of the key questions about the agreements the Trump administration has reached with drugmakers on pricing.